PRX-08066

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NamePRX-08066
Drug Alias NamePRX-8066PRX-08066
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2b (5-HT2b) receptor antagonists
TargetsSerotonin 2b (5-HT2b) receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveHypertension, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEpix Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveHypertension, Pulmonary

Other Information

ATC CodeN/A
Related LinksWikipedia